Role of calcium and cyclic adenosine 3',5'-monophosphate in the antilipolytic effect of tolbutamide and glibenclamide.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000273:Adipose Tissue / Q000201:enzymology / Q000378:metabolism; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology / Q000502:physiology*; D002264:Carboxylic Acids / Q000494:pharmacology; D000242:Cyclic AMP / Q000502:physiology*; D004837:Epinephrine / Q000494:pharmacology; D005934:Glucagon / Q000494:pharmacology; D005905:Glyburide / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D013806:Theophylline / Q000494:pharmacology; D014044:Tolbutamide / Q000031:analogs & derivatives / Q000494:pharmacology*
D002264:Carboxylic Acids; D003994:Bucladesine; D000324:Adrenocorticotropic Hormone; D005934:Glucagon; D014044:Tolbutamide; D013806:Theophylline; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D007545:Isoproterenol; D005905:Glyburide; D002118:Calcium; D009638:Norepinephrine; D004837:Epinephrine